UnitedHealth Stock Has Quietly Soared 80% off Its Low. Is the Worst Finally Behind It?

UnitedHealth stock has rebounded 80% from its 2025 low of $234.60 to near $427, outpacing the S&P 500. The company's medical care ratio improved and management raised 2026 earnings guidance, signaling operational stabilization. However, the stock's forward P/E ratio has risen to 23 from 13, and an unresolved Department of Justice investigation into Medicare Advantage billing practices creates uncertainty. The analyst suggests the easy gains have been made and recommends watching from the sidelines.

06/27/2026, 6:03 AM • The Motley Fool

UnitedHealth is Near its 52-Week High. Wall Street Is Starting to Notice This Blue Chip Stock -- and So Should You.

UnitedHealth Group (UNH) has surged 25% this year and is trading near its 52-week high. The healthcare giant offers revenue growth, a solid 2.3% dividend yield with 17 consecutive years of increases, and resilience against economic downturns. The company is deploying a $1.5 billion AI initiative to reduce administrative costs and improve margins, while managing rising medical costs through responsive pricing strategies. Despite valuation concerns and industry-wide medical cost pressures, UnitedHealth's diversified business model and strong cash flow position it as an attractive investment for income and total-return focused investors.

06/26/2026, 3:30 PM • The Motley Fool

Is UnitedHealth Stock an Undervalued Healthcare Stock to Buy?

UnitedHealth Group stock has been rising in recent months, but investors should remain cautious. The article suggests that investors are appreciating management's response to higher customer-service costs, though the stock's recent gains warrant careful consideration before investing.

06/25/2026, 6:22 PM • The Motley Fool

Modern Therapy Group launches virtual intensive outpatient program for mental health

Modern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults with depression, anxiety, trauma, and other mental health conditions. The program offers five days a week of clinician-led telehealth treatment, providing a middle ground between weekly therapy and inpatient care. Available in seven states with in-network coverage from major insurers including Blue Cross Blue Shield, Aetna, Cigna, and Optum/United.

06/24/2026, 6:54 PM • GlobeNewswire

2 Top-Tier Dividend ETFs that Complement Each Other Well to Invest in Right Now

The Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Dividend Appreciation ETF (VIG) are complementary dividend ETFs that together offer both high income and growth potential. SCHD focuses on high-quality dividend-paying companies and offers higher yields, while VIG emphasizes dividend growth and has greater exposure to tech stocks like Apple and Microsoft, providing better stock price appreciation.

06/21/2026, 10:30 AM • The Motley Fool

Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider

The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion and Europe USD 6.25 trillion by 2035. Hospital services will dominate with 44% market share, while telehealth services will experience the fastest growth.

06/20/2026, 4:27 AM • GlobeNewswire

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock?

Mizuho analyst Ann Hynes raised her CVS Health price target to $115 per share, implying 13% upside from current levels. The article suggests CVS could see even greater upside potential, potentially reaching $150 per share if it achieves a valuation multiple similar to UnitedHealth Group, given its transformation into a diversified healthcare services company and expected double-digit earnings growth.

06/15/2026, 4:15 PM • The Motley Fool

Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit

The healthcare sector added 35,200 jobs in May, with ambulatory services leading at 25,700 positions and hospitals adding 6,000. This consistent job growth signals sustained demand for healthcare services and revenue opportunities for companies positioned in ambulatory care, managed care, and inpatient rehabilitation. Three stocks are highlighted as beneficiaries of this trend: UnitedHealth Group, HCA Healthcare, and Encompass Health.

06/15/2026, 1:36 PM • Investing

UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?

UnitedHealth Group has rebounded to a 52-week high with a 23% gain year-to-date, driven by better-than-expected Medicare Advantage reimbursement rates and improved margins. However, the stock remains down 34% from two years ago. The company faces significant dependency on government funding, with 44% of revenue from Medicare and Medicaid, creating uncertainty about future profitability if reimbursement rates decline.

06/11/2026, 4:32 PM • The Motley Fool

S&P 500 Selloff Looks More Like Rotation Than Market Breakdown

A stronger-than-expected May jobs report (172,000 payrolls vs. 80,000-105,000 forecast) triggered a market rotation rather than a broad selloff. The strong labor data pushed Treasury yields to 4.54%, reducing rate-cut expectations and hitting rate-sensitive tech stocks. While the Nasdaq fell 1.13% and semiconductor stocks cratered, the Russell 2000 surged 1.45% as money rotated into cyclicals and small caps. The Dow held near record highs, indicating broadening market participation rather than a systemic breakdown.

06/05/2026, 1:36 PM • Investing

UnitedHealth Positioned As AI Leader: Analyst

Morgan Stanley raised UnitedHealth's price target to $453 from $395 and named it a top pick, citing the company's leadership in AI adoption within managed care. The firm believes AI deployment could drive operational improvements, enhance medical loss ratios, and create new revenue opportunities, with potential for roughly 45% average earnings per share upside as efficiencies scale. UnitedHealth shares were trading near their 52-week high.

06/05/2026, 10:05 AM • Benzinga

Why Is UnitedHealth Stock Gaining Thursday?

UnitedHealth Group (UNH) surged 5.14% on Thursday following upgrades from Bank of America Securities (raising price target to $450) and Morgan Stanley (raising to $453). The gains were driven by improved Medicare Advantage rate announcements showing a 2.48% payment increase for 2027, easing medical cost trends, and potential AI-driven benefits for managed care organizations. The company also raised its fiscal 2026 adjusted EPS guidance to over $18.25.

06/04/2026, 1:11 PM • Benzinga

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

Warren Buffett and Greg Abel's Berkshire Hathaway portfolio is notably absent from the healthcare sector, holding only DaVita and recently exiting UnitedHealth Group. The article argues investors should consider healthcare independently, as it offers opportunities across multiple investment styles—from high-growth pharma/biotech plays like Eli Lilly to dividend-paying stalwarts like Johnson & Johnson and Abbott Laboratories that provide steady earnings and income.

06/03/2026, 12:05 PM • The Motley Fool

Berkshire Hathaway Made Some Major Portfolio Moves, but This One Was a Head-Scratcher. How Should Investors Take It?

Berkshire Hathaway's latest 13F filing reveals significant portfolio changes under new CEO Greg Abel, including exits from Visa, Mastercard, UnitedHealth Group, and Amazon. Most notably, Berkshire purchased 39.8 million shares of Delta Air Lines worth $3.28 billion, marking its return to the airline industry after previous losses during COVID-19. The move signals new management implementing different strategies, with Delta trading at attractive valuations below 10x earnings.

06/03/2026, 3:05 AM • The Motley Fool

Warren Buffett's Successor, Greg Abel, Just Sold UnitedHealth Group Stock. Is He Missing a Huge Opportunity?

Greg Abel, Berkshire Hathaway's new CEO, sold the company's entire 5.1 million-share stake in UnitedHealth Group in Q1 2026 as part of portfolio spring cleaning. While UnitedHealth shares have rallied over 40% since the sale, the author argues Abel made the right call given the stock's valuation risks and the company's ongoing turnaround challenges. Berkshire also exited positions in Amazon, Domino's, Mastercard, and Visa while increasing stakes in Alphabet and adding new positions in Delta Airlines and Macy's.

05/27/2026, 3:32 PM • The Motley Fool